(Reuters) – India’s Cipla Ltd has been granted a new drug permission for restricted use of Moderna Inc’s COVID-19 vaccine in the country, a senior government official said on Tuesday.
(Reporting by Bhargav Acharya in Bengaluru; Editing by Louise Heavens)
